First Time Loading...

Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882

Watchlist Manager
Guangzhou Kingmed Diagnostics Group Co Ltd Logo
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Watchlist
Price: 38.35 CNY -4.84% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Guangzhou Kingmed Diagnostics Group Co Ltd stock under the Base Case scenario is 70.55 CNY. Compared to the current market price of 38.35 CNY, Guangzhou Kingmed Diagnostics Group Co Ltd is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
70.55 CNY
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
96
vs Industry
52
Median 3Y
2.9
Median 5Y
3.2
Industry
2.4
Forward
2.1
More Details
20.4
P/E
P/E
Price to Earnings
20.4
vs History
68
vs Industry
28
Median 3Y
22.4
Median 5Y
32.8
Industry
23.2
Forward
24.7
More Details
16
P/OCF
P/OCF
Price to OCF
16
vs History
88
vs Industry
26
Median 3Y
22.1
Median 5Y
26.4
Industry
15.5
More Details
56.7
P/FCFE
P/FCFE
Price to FCFE
56.7
vs History
55
vs Industry
11
Median 3Y
51.8
Median 5Y
64.4
Industry
23.5
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
96
vs Industry
41
Median 3Y
4.5
Median 5Y
7.9
Industry
2.2
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
96
vs Industry
54
Median 3Y
2.8
Median 5Y
3.2
Industry
2.5
Forward
1.9
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
90
vs Industry
47
Median 3Y
6.8
Median 5Y
8.3
Industry
5.2
More Details
22.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.8
vs History
57
vs Industry
14
Median 3Y
17.5
Median 5Y
28.5
Industry
12.5
Forward
13.5
More Details
22.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.8
vs History
57
vs Industry
21
Median 3Y
17.5
Median 5Y
28.5
Industry
17.2
Forward
24.7
More Details
14.5
EV/OCF
EV/OCF
Enterprise Value to OCF
14.5
vs History
88
vs Industry
30
Median 3Y
20.7
Median 5Y
25.5
Industry
15.1
More Details
47.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
47.9
vs History
61
vs Industry
10
Median 3Y
43.1
Median 5Y
57.9
Industry
19.7
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
96
vs Industry
37
Median 3Y
4.5
Median 5Y
6.5
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Guangzhou Kingmed Diagnostics Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
18B CNY 1.9 20.4 22.8 22.8
US
Cigna Corp
NYSE:CI
104.5B USD 0.5 20.2 10.4 13.9
US
Cigna Group
XMUN:CGN
96.9B EUR 0.5 20.1 10.3 13.7
US
CVS Health Corp
NYSE:CVS
72.5B USD 0.2 8.7 7.9 7.9
DE
Fresenius Medical Care AG
XMUN:FME
22.7B EUR 0.6 22.8 10.6 25.1
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.2 11.9 18
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.9B EUR 0.7 -26.7 10.1 22.7
US
Quest Diagnostics Inc
NYSE:DGX
15.3B USD 1.6 18.1 10.8 14.7
US
DaVita Inc
NYSE:DVA
12.4B USD 1 18 8.6 12.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.9B EUR 0.6 23.7 7 16.6
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.